Cristin-resultat-ID: 2020952
Sist endret: 1. november 2022, 12:40
NVI-rapporteringsår: 2022
Resultat
Vitenskapelig artikkel
2022

Effectiveness of the advisory display SmartPilot® view in the assessment of anesthetic depth in low risk gynecological surgery patients: a randomized controlled trial

Bidragsytere:
  • Hilde Strand
  • Ann Charlott Elshaug
  • Øyvind Bernersen og
  • Randi Ballangrud

Tidsskrift

BMC Anesthesiology
ISSN 1471-2253
e-ISSN 1471-2253
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2022
Publisert online: 2022
Volum: 22
Artikkelnummer: 57
Open Access

Importkilder

Scopus-ID: 2-s2.0-85125660204

Beskrivelse Beskrivelse

Tittel

Effectiveness of the advisory display SmartPilot® view in the assessment of anesthetic depth in low risk gynecological surgery patients: a randomized controlled trial

Sammendrag

Background: Assessment of appropriate anesthetic depth is crucial to prevent harm to patients. Unnecessary deep anesthesia can be harmful, potentially causing acute renal failure, myocardial injury, delirium, and an increased mortality rate. Conversely, too light anesthesia combined with muscle relaxants can result in intraoperative patient awareness and lead to serious psychological trauma. This trial aimed to ascertain the efectiveness of the advisory display SmartPilot View (SPV), as a supplemental measure in the assessment of anesthetic depth in low risk gynecological surgery patients. The hypothesis was that the use of the SPV would increase the precision of assessment, and result in a higher mean arterial pressure. Methods: This trial used a randomized, controlled, single-blind design with a homogeneous sample. Patients undergoing minor, low risk gynecological surgery were randomly assigned to two groups: a test group wherein current standards were supplemented with the advisory display SPV and a control group assessed using only the current standards. Female patients aged between 18 and 75 years with American Society of Anesthesiologists Physical Status Classifcation System scores of 1–3 undergoing planned general anesthesia using the total intravenous anesthetic method, combining propofol and remifentanil, were included. The exclusion criteria included a body mass index≥35 kg/m2 , a history of alcoholism, drug intake afecting propofol and remifentanil dynamics, and inability to consent. The independent sample t-test and chi-square test or Fisher’s exact test were used to assess the statistical signifcance of diferences between the two groups. Results: A total of 114 patients were included in the analysis (test group n=58, control group n=56). No signifcant diferences in the mean arterial pressure, heart rate, bispectral index, extubation delay, or post-anesthesia care unit stay were found between groups. Conclusions: The addition of the advisory display SmartPilot® View to current standards in the evaluation of anesthetic depth had no signifcant efect on the outcome. Trial registration: The trial was registered on January 16th 2019 with ClinicalTrials.gov (ref: NCT03807271).

Bidragsytere

Hilde Strand

  • Tilknyttet:
    Forfatter
    ved Div Gjøvik/Lillehammer ved Sykehuset Innlandet HF

Ann Charlott Elshaug

  • Tilknyttet:
    Forfatter
    ved Operasjonsavdelingen ved Sykehuset Østfold HF

Øyvind Bernersen

  • Tilknyttet:
    Forfatter
    ved Avd Akuttmedisin Lillehammer ved Sykehuset Innlandet HF

Randi Ballangrud

  • Tilknyttet:
    Forfatter
    ved Institutt for helsevitenskap Gjøvik ved Norges teknisk-naturvitenskapelige universitet
1 - 4 av 4